India's Pharmaceutical Exports

Country Profile

Suriname

Suriname is a developing market for Indian pharmaceuticals — $3.00M in FY 2025–26, with 3.6× growth over the past decade. Medicines accounts for 75% of shipments, with vaccines contributing $103K. The compound annual growth rate since FY2015 stands at 12.2%.

🇸🇷 $3.00M · 3.6× growth since FY2015 · 12.2% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$3.00M
Exports FY2025–26 DGCIS
3.6×
Growth FY2015→2026
12.2%
CAGR FY2015→2026
75%
Medicines Share
5
Product Categories Supplied
Suriname is a developing market for Indian pharmaceuticals — $3.00M in FY 2025–26, with 3.6× growth over the past decade. Medicines accounts for 75% of shipments, with vaccines contributing $103K. The compound annual growth rate since FY2015 stands at 12.2%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $2.26M (75.3%) Surgical & Hospital Supplies $500K (16.7%) Vaccines $103K (3.4%) Traditional & Herbal $88K (2.9%) Medicine Ingredients $49K (1.6%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Suriname in the RBI overseas direct investment dataset (2011–2026).